Evidence map›Paper›PMID 42639392›Full record

ArticleERJ open research2026

Lung fibroblasts contribute to release of serum amyloid A as potential biomarker of exacerbation of lung fibrosis in mice.

Lara-Kristin Steinmetz, Benjamin Seeliger, Jonas Schupp, Tina Röpke, Franziska Aschenbrenner, Regina Maus, David S DeLuca, Svenja Gaedcke, Andreas Pich, Lars Knudsen and 5 more

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lara-Kristin SteinmetzDivision of Experimental Pneumology, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0009-0004-7280-2122
Benjamin SeeligerGerman Center for Lung Research, partner site Hannover, Hannover, Germany.ORCID https://orcid.org/0000-0001-7373-752X
Jonas SchuppGerman Center for Lung Research, partner site Hannover, Hannover, Germany.ORCID https://orcid.org/0000-0002-7714-8076
Tina RöpkeDivision of Experimental Pneumology, Hannover Medical School, Hannover, Germany.
Franziska AschenbrennerDivision of Experimental Pneumology, Hannover Medical School, Hannover, Germany.
Regina MausDivision of Experimental Pneumology, Hannover Medical School, Hannover, Germany.
David S DeLucaGerman Center for Lung Research, partner site Hannover, Hannover, Germany.
Svenja GaedckeGerman Center for Lung Research, partner site Hannover, Hannover, Germany.ORCID https://orcid.org/0000-0001-7336-7354
Andreas PichInstitute of Toxicology and Core Facility Proteomics, Hannover Medical School, Hannover, Germany.
Lars KnudsenInstitute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.
Lavinia NeubertGerman Center for Lung Research, partner site Hannover, Hannover, Germany.
Fabio IusDepartment of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Antje PrasseGerman Center for Lung Research, partner site Hannover, Hannover, Germany.ORCID https://orcid.org/0000-0002-7336-7458
Martin KolbDepartment of Medicine, Pathology, and Molecular Medicine, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-3837-1467
Ulrich A MausDivision of Experimental Pneumology, Hannover Medical School, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fibroblasts are important contributors to collagen deposition in interstitial lung diseases (ILD), but their inflammatory role in acute exacerbation of ILD including idiopathic pulmonary fibrosis is currently undefined. Methods: Using a well-described model of Results: Lung fibroblasts responded to pneumococcal challenge with increased SAA mRNA and protein levels Conclusion: Analysis of plasma levels of SAA protein may aid in the identification of underlying inflammation in patients with ILD who are more likely to deteriorate towards a critical clinical stage during acute exacerbation.

Identifiers

PMID42639392
PMCPMC13501457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.